Status:
COMPLETED
MRP Verses PNF on Pain, Foot Drop, Gait and Functional Mobility in Hemiplegic Patients.
Lead Sponsor:
University of Lahore
Conditions:
Stroke
Pain
Eligibility:
All Genders
45-65 years
Phase:
NA
Brief Summary
This single blinded randomized control study aimed to determine the comparative effectiveness of two rehabilitation approaches for improving pain, foot drop, gait, and functional mobility in patients ...
Detailed Description
Stroke is a leading cause of disability worldwide, with hemiplegia (muscle weakness or paralysis on one side of the body) being a common consequence. Rehabilitation plays a crucial role in improving g...
Eligibility Criteria
Inclusion
- Patients having age between 45 to 65 years (Kagawa et al., 2013)
- Hemiplegic, impaired functional mobility and dependent (Kanase, 2020)
- Functional deficits in lower limb, with both the Sexes and any side (left or right) (Kanase, 2020)
- Patients having hemiplegia within 6 months might be post-stroke, able to follow instructions (Kanase, 2020)
- Diagnosed with hemiplegia having a stable neurological condition (e.g., stroke) (Anandan et al., 2020)
- Minimum score of 12 on the Dynamic Gait Index (DGI) to ensure sufficient baseline gait function for meaningful comparison (Singha, 2017).
- Grade 3 foot drop (Tibialis Anterior) on the Motor Assessment Scale in the affected leg to have room for improvement in both interventions (Singha, 2017).
- Participants having moderate to severe pain of ≤ 4 (moderate) and ≥ 7 (severe) on numeric pain rating scale (NPRS) at rest , were included to minimize confounding effects of pain on gait and mobility (Beebe et al., 2021).
- Mini-Mental State Examination (MMSE) score ≥ 24 (Page et al., 2007).
Exclusion
- Subjects having any medical condition that affects his/her performance (Kanase, 2020)
- Completely recovered case of Hemiplegia in terms of walking abilities \& upper limb activities (Kanase, 2020)
- Subjects with Transient Ischemic Attack (Kanase, 2020)
- Other neurological conditions such as severe cognitive impairments
Key Trial Info
Start Date :
January 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 17 2024
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06539247
Start Date
January 28 2024
End Date
December 17 2024
Last Update
December 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Lahore
Lahore, Punjab Province, Pakistan, 54590